Atopic Dermatitis

• FDA label_change · 2026-03-16
  FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)

  FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical …

• FDA label_change · 2025-12-12
  FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)

  The FDA approved a supplemental application for Adbry (tralokinumab-ldrm) from LEO Pharma Inc.

• FDA label_change · 2025-05-22
  FDA Approved: EBGLYSS — Supplemental Application (Eli Lilly and Company)

  FDA approved a supplemental application for EBGLYSS (lebrikizumab-lbkz) from Eli Lilly, affecting the drug's label.

• FDA label_change · 2025-03-26
  FDA Approved: RINVOQ — Supplemental Application (AbbVie Inc.)

  FDA approved AbbVie’s supplemental application for Rinvoq (upadacitinib), resulting in a labeling update for the product.

• FDA label_change · 2024-06-11
  FDA Approved: HYDROCORTISONE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a Supplemental Application for HYDROCORTISONE from Aurobindo Pharma Limited, typically indicating a label change for this gener…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2023-07-17
  FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Viona Pharmaceuticals Inc)

  The FDA approved a supplemental application for Betamethasone Dipropionate from Viona Pharmaceuticals Inc, typically reflecting labeling cha…

• FDA label_change · 2023-05-10
  FDA Approved: METHYLPREDNISOLONE ACETATE — Supplemental Application (Sandoz Inc.)

  FDA approved a supplemental application for methylprednisolone acetate by Sandoz Inc.

• FDA label_change · 2017-01-13
  FDA Approved: CORDRAN — Supplemental Application (Almirall, LLC)

  FDA approved a supplemental application for CORDRAN (flurandrenolide) filed by Almirall, LLC, likely affecting labeling.

• FDA label_change · 2016-11-02
  FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)

  FDA approved a supplemental application for Tridesilon Cream (desonide 0.05%), updating the product labeling.

• FDA label_change · 2015-06-29
  FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approves a supplemental application for clobetasol propionate from Actavis Pharma, Inc. to update the product labeling.

• FDA label_change · 2015-05-21
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories to update the product labeling.

• FDA label_change · 2014-10-30
  FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)

  FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, resulting in changes to the product labe…

• FDA label_change · 2014-04-02
  FDA Approved: HALOG — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA supplemental application for HALOG (halcinonide cream) submitted by Sun Pharmaceutical Industries, Inc., with the submission status indi…

• FDA label_change · 2012-12-07
  FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc., updating the product labeling. This…

• FDA label_change · 2012-09-07
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. The approval updates the product…

• FDA label_change · 2011-01-12
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  FDA approved a supplemental labeling change for Clobex (clobetasol propionate) by Galderma Laboratories.

• FDA label_change · 2009-06-10
  FDA Approved: HALOG — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for HALOG (halcinonide cream) from Sun Pharmaceutical, resulting in updated product labeling.

• FDA label_change · 2007-12-12
  FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)

  FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…